z-logo
open-access-imgOpen Access
Novel Budesonide Suppository and Standard Budesonide Rectal Foam Induce High Rates of Clinical Remission and Mucosal Healing in Active Ulcerative Proctitis: a Randomised, Controlled, Non-inferiority Trial
Author(s) -
Wolfgang Kruis,
Britta Siegmund,
Konrad Leśniakowski,
В. И. Симаненков,
Л. В. Хіміон,
Marcin Soboń,
Glebs Delmans,
Svetlana V Maksyashina,
О. А. Саблин,
Juris Pokrotnieks,
Yuriy Mostovoy,
Olena Datsenko,
Sayar Abdulkhakov,
A. E. Dorofeyev,
Olena Levchenko,
Olga Alexeeva,
П. С. Андреев,
Ivan P Kolesnik,
Emese Mihály,
О. Аbrahamovych,
Malgorzata Baluta,
N. M. Kharchenko,
Neshta Viacheslav,
Yury P. Uspenskiy,
Michael Vieth,
Ralf Mohrbacher,
Ralph Müeller,
Roland Greinwald
Publication year - 2022
Publication title -
journal of crohn s and colitis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.277
H-Index - 80
eISSN - 1876-4479
pISSN - 1873-9946
DOI - 10.1093/ecco-jcc/jjac081
Subject(s) - suppository , budesonide , medicine , ulcerative colitis , proctitis , gastroenterology , clinical endpoint , clinical trial , rectum , placebo , randomized controlled trial , surgery , corticosteroid , pharmacology , disease , pathology , alternative medicine

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom